Filtros de búsqueda

Lista de obras de

A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study

scientific article published on 10 July 2019

Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports.

artículo científico publicado en 2005

Granulocyte-colony-stimulating Factor for Acute Ischemic Stroke: A Randomized Controlled Trial (STEMTHER).

artículo científico publicado en 2011

HLA-DRB1*16-restricted recognition of myeloid cells, including CD34+ CML progenitor cells

artículo científico publicado en 2003

Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response.

artículo científico publicado en 2005

Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial

artículo científico publicado en 2020

Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.

artículo científico publicado en 2007

T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.

artículo científico publicado en 2006

UTY-specific TCR-transfer generates potential graft-versus-leukaemia effector T cells

artículo científico publicado en 2005

[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study].

artículo científico publicado en 2016

[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]

scientific article published on 01 January 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda